Erlotinib-related Corneal Melting Reply

被引：1
|
作者：
Molina-Prat, Nicolas [1 ]
Saint-Jean, Alejandro [1 ]
Sainz de la Maza, Maite [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
OPHTHALMOLOGY | 2013年 / 120卷 / 05期
关键词：
CANCER; EGFR;
D O I：
10.1016/j.ophtha.2012.12.024
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1104 / 1105
页数：4
相关论文
共 50 条
  • [1] DESCRIPTION OF PATIENTS WITH ERLOTINIB-RELATED SKIN EFFECTS IN FRANCE
    Janus, N.
    Robert, C.
    Souquet, P.
    Deplanque, G.
    Launay-Vacher, V.
    Mateus, C.
    Dreno, B.
    Deray, G.
    Morere, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 103 - 103
  • [2] Successful retreatment with erlotinib after erlotinib-related interstitial lung disease
    Turk, Haci M.
    Adli, Mustafa
    Simsek, Melih
    Aliyev, Altay
    Besiroglu, Mehmet
    TUMORI JOURNAL, 2021, 107 (06): : NP84 - NP86
  • [3] Frequency and current management of erlotinib-related skin effects
    Souquet, P.
    Deplanque, G.
    Janus, N.
    Launay-Vacher, V.
    Robert, C.
    Mateus, C.
    Dreno, B.
    Deray, G.
    Morere, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer
    Nam, Hae-Seong
    Lee, Hyeon-Jeong
    Kim, Min Su
    Park, Sung Wook
    Jeon, Sang-Hoon
    Cho, Jae Hwa
    Kwak, Seung Min
    Lee, Hong Lyeol
    Ryu, Jeong-Seon
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2010, 69 (06) : 465 - 468
  • [5] Erlotinib-related keratopathy in a patient underwent laser in situ keratomileusis
    Kau, Hui-Chuan
    Tsai, Chieh-Chih
    CUTANEOUS AND OCULAR TOXICOLOGY, 2016, 35 (03) : 257 - 259
  • [6] Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction
    Marta Koršić
    Davorka Muršić
    Sonja Badovinac
    Nada Božina
    Mihovil Roglić
    Marko Jakopović
    Branka Čučević
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1317 - 1319
  • [7] Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction
    Korsic, Marta
    Mursic, Davorka
    Badovinac, Sonja
    Bozina, Nada
    Roglic, Mihovil
    Jakopovic, Marko
    Cucevic, Branka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1317 - 1319
  • [8] Description of erlotinib-related skin effects management in France. Results of the PRECEDE study
    Janus, N.
    Launay-Vacher, V.
    Robert, C.
    Souquet, P-J
    Mateus, C.
    Dreno, B.
    Deray, G.
    Morere, J. F.
    Deplanque, G.
    CANCER RADIOTHERAPIE, 2009, 13 (02): : 97 - 102
  • [9] CORNEAL MELTING SYNDROME - REPLY
    YANG, HK
    KLINE, OR
    ARCHIVES OF OPHTHALMOLOGY, 1983, 101 (02) : 303 - 303
  • [10] Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects
    Hwang, In Gyu
    Kang, Jung Hun
    Oh, Sung Yong
    Lee, Suee
    Kim, Sung-Hyun
    Song, Ki-Hoon
    Son, Choonhee
    Park, Min Jae
    Kang, Myung Hee
    Kim, Hoon Gu
    Lee, Jeeyun
    Park, Young Suk
    Sun, Jong Mu
    Kim, Hyun Jung
    Kim, Chan Kyu
    Yi, Seong Yoon
    Jang, Joung-Soon
    Park, Keunchil
    Kim, Hyo-Jin
    SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 301 - 309
12345